Nanotechnology Characterization Lab.,
Cancer Research Technology Program,
Nanotechnology Characterization Lab., Cancer Research Technology Program
Marina A. Dobrovolskaia has not added Biography.
If you are Marina A. Dobrovolskaia and would like to personalize this page please email our Author Liaison for assistance.
Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro.
Molecules (Basel, Switzerland) Jul, 2018 | Pubmed ID: 30002298
Animal models for analysis of immunological responses to nanomaterials: Challenges and considerations.
Advanced drug delivery reviews Nov - Dec, 2018 | Pubmed ID: 30273617
Roadmap and strategy for overcoming infusion reactions to nanomedicines.
Nature nanotechnology Dec, 2018 | Pubmed ID: 30348955
Frederick National Laboratory for Cancer Research sponsored by National Cancer Institute
Barry W. Neun1,
Marina A. Dobrovolskaia1
1Nanotechnology Characterization Lab., Cancer Research Technology Program, Frederick National Laboratory for Cancer Research sponsored by National Cancer Institute
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
Research
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
Education
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
Authors
Librarians
Access
ABOUT JoVE
JoVE Sitemap
Copyright © 2025 MyJoVE Corporation. All rights reserved